Experience

Synexus has conducted over 160 late-stage studies recruited over 18,000 patients and developed a network of worldwide centres over the past five years.

Synexus has worked with some of the world’s largest pharmaceutical companies including:

  • Merck
  • Glaxo SmithKline
  • J&J
  • Pfizer
  • Astra Zeneca
  • Novartis
  • Roche
  • Amgen
  • Bayer
  • Solvay
  • Schering-Plough
  • BI
  • Daiichi
  • P&G

Synexus has also worked with some of the largest CROs including:

  • Quintiles
  • Paraxel
  • Covance
  • Chiltern
  • Icon
  • MDS Pharma

Synexus has a wide portfolio of experience encompassing a number of therapy areas and is currently engaged with studies in the UK, across Central Eastern Europe, Indian and South Africa. However, the Synexus model can be translated against all conditions and therapy areas which are treated in a primary care setting.

The principal therapeutic areas Synexus has been involved in include:

  • Osteoporosis 
  • Osteoarthritis
  • Migraine
  • Diabetes
  • Sexual dysfunction
  • IBS
  • HRT
  • Urinary incontinence
  • Anxiety
  • Depression
  • Obesity
  • Disease prevention including cancer, osteoporosis, cardiovascular disease and diabetes